Oversea-Chinese Banking Corp (OCBC)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-66,302
Closed -$4.4M 344
2025
Q4
$4.4M Buy
66,302
+9,759
+17% +$631K 0.12% 115
2025
Q3
$3.8M Sell
56,543
-4,229
-7% -$335K 0.09% 128
2025
Q2
$5.3M Buy
60,772
+14,229
+31% +$1.12M 0.15% 102
2025
Q1
$3.18M Buy
46,543
+39,688
+579% +$3.24M 0.09% 141
2024
Q4
$533K Buy
6,855
+3,558
+108% +$263K 0.02% 276
2024
Q3
$221K Buy
+3,297
New +$271K 0.01% 376
2023
Q1
Sell
-2,524
Closed -$286K 337
2022
Q4
$286K Buy
+2,524
New +$277K 0.02% 296

Other funds holding DXCM

Oversea-Chinese Banking Corp (OCBC)'s DXCM Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of DexCom (DXCM) in Q1 2026, closing a stake of 66,302 shares — an estimated $4.4M sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $5.3M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 66,302 DexCom shares in Q1 2026, an estimated $4.4M.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s DexCom position peaked at $5.3M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.